5.4. Analysis.
Comparison 5: Gemcitabine versus one‐third dose Bacillus Calmette‐Guérin (BCG), Outcome 4: Grade I or II adverse events
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.